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Results BA supplementation had no effect on volun-
tary or electrically  evoked isometric force production, or 
twitch electromechanical delay and time-to-peak tension. 
There was a significant decline in muscle HRT in fresh and 
fatigued muscle conditions  during both resting (3 ± 13%; 
19 ± 26%) and potentiated (1 ± 15%; 2 ± 20%) twitch 
contractions.
Conclusions The mechanism for reduced HRT in fresh 
and fatigued skeletal muscle following BA supplementation 
is unclear. Due to the importance of muscle relaxation on 
total energy consumption, especially during short, repeated 
contractions, BA supplementation may prove to be benefi-
cial in minimising contractile slowing induced by fatigue.
Trial registration The trial is registered with Clinicaltri-
als.gov, ID number NCT02819505.
Keywords Contractile properties · Electrical stimulation · 
Muscle fatigue · Carnosine
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EMD  Electromechanical delay
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HRT  Half-relaxation time
Mmax  The mean M-wave area of the three supramaxi-
mal stimuli
M-wave  Muscle action potential
MVIC  Maximal voluntary isometric contraction
MVIF  Maximal voluntary isometric force
Abstract 
Purpose In fresh muscle, supplementation with the rate-
limiting precursor of carnosine, β-alanine (BA), results in 
a decline in muscle half-relaxation time (HRT) potentially 
via alterations to calcium  (Ca2+) handling. Accumulation 
of hydrogen cation  (H+) has been shown to impact  Ca2+ 
signalling during muscular contraction, carnosine has the 
potential to serve as a cytoplasmic regulator of  Ca2+ and 
 H+ coupling, since it binds to both ions. The present study 
examined the effect of BA supplementation on intrinsic 
in-vivo isometric knee extensor force production and mus-
cle contractility in both fresh and fatigued human skeletal 
muscle assessed during voluntary and electrically evoked 
(nerve and superficial muscle stimulation) contractions.
Methods Twenty-three males completed two experimen-
tal sessions, pre- and post- 28 day supplementation with 
6.4 g.day−1 of BA (n = 12) or placebo (PLA; n = 11). Iso-
metric force was recorded during a series of voluntary and 
electrically evoked knee extensor contractions.
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PLA  Placebo
RF  Rectus femoris
RMS  Root mean squared
TPT  Time-to-peak tension
TTF  Time-to-task failure
VL  Vastus lateralis
VM  Vastus medialis
Introduction
Carnosine (β-alanyl-L-histidine) is a cytoplasmic dipep-
tide, synthesised from β-alanine (BA) and histidine and is 
found in high concentrations in skeletal muscle. The syn-
thesis of carnosine is limited by the availability of BA from 
the diet, while supplementation with BA over a number of 
weeks results in significant increases in the skeletal muscle 
carnosine content (Harris et al. 2006; Hill et al. 2007). BA 
supplementation has been shown to consistently increase 
human skeletal muscle carnosine concentrations, and by 
an equal amount in both type I and II muscle fibres (Hill 
et  al. 2007), with increases of 40–80% evident depending 
upon dose (3.2–6.4 g day−1) and duration of administration 
(4–10 weeks) (Harris et al. 2006; Hill et al. 2007). Increas-
ing skeletal muscle carnosine concentrations via BA sup-
plementation in both upper and lower limbs has consist-
ently been shown to benefit high-intensity exercise capacity 
and performance, as highlighted by several reviews (Sale 
et al. 2010, 2013) and a recent meta-analysis (Hobson et al. 
2012).
With a pKa of 6.83 for the histidine imidazole ring when 
combined with BA and the abundance of carnosine within 
skeletal muscle, it has been proposed that the improve-
ments in high-intensity exercise outcomes following BA 
supplementation are the result of increased muscle buffer-
ing capacity over the exercise pH transit range (Hill et al. 
2007). Whilst the role of carnosine as an intracellular pH 
buffer is undisputable, other physiological roles for carno-
sine underlying high-intensity exercise improvements fol-
lowing BA supplementation have been proposed (Sale et al. 
2010). Carnosine can increase the sensitivity of the calcium 
 (Ca2+) release channels in the sarcoplasmic reticulum and/
or the sensitivity of the contractile apparatus in chemi-
cally skinned muscle fibres from frogs (Lamont and Miller 
1992), mechanically skinned rat muscle fibres (Dutka and 
Lamb 2004) and type I and type II human skeletal muscle 
fibres (Dutka et  al. 2012). Muscle  Ca2+ release channels 
contain saturable binding sites for carnosine, indicating that 
carnosine has the potential to alter the  Ca2+ channel itself 
(Batrukova and Rubstov 1997). Until recently, however, 
research has been limited to rodent and in-vitro models.
Recent work (Hannah et  al. 2015) examined the 
effect of BA supplementation on human skeletal muscle 
contractile properties and force production capabilities 
in-vivo. BA supplementation did not alter maximal or 
explosive voluntary isometric force production, or the 
force–frequency relationship (Hannah et  al. 2015), this 
relationship is the in-vivo analogue of the force–cal-
cium concentration relationship (Batrukova and Rubstov 
1997). These findings were in-line with the hypothesis 
arising from our previous exercise performance studies 
(Sale et  al. 2010, 2013) proposing that the main physi-
ological role for carnosine in improving high-intensity 
exercise performance related to intracellular pH buffering 
and not to increased  Ca2+ sensitivity of the in-vivo con-
tractile apparatus. An unexpected result was a significant 
decline in half-relaxation time (HRT) during both rest-
ing and potentiated twitches following BA supplementa-
tion, making it important to confirm these findings before 
exploring potential underlying mechanisms. Muscle 
relaxation speed can be impacted by the rate of: (1) disso-
ciation of  Ca2+ from troponin (Little et al. 2011); (2) the 
rate of translocation of  Ca2+ to near the site of entry into 
the sarcoplasmic reticulum (Muntener et al. 1995); (3) re-
uptake of  Ca2+ into the sarcoplasmic reticulum by  Ca2+ 
pumps (Nogueira et  al. 2013) and cross-bridge detach-
ment (Allen et  al. 2008). Slowing of skeletal muscle 
relaxation decreases power output and shortening veloc-
ity (Allen et al. 2008), thus limiting performance during 
dynamic exercise where rapidly alternating movements 
are performed (Allen et al. 1995). Improving the relaxa-
tion of skeletal muscle can be energetically beneficial by 
increasing the efficiency of joint movements by reduced 
co-contraction (Nogueira et  al. 2013). This would be 
expected to contribute to enhanced dynamic exercise 
performance, especially where rapidly alternating move-
ments are performed.
High-intensity exercise leads to a more pronounced 
accumulation of hydrogen cation  (H+), a metabolic fac-
tor which might be involved in skeletal muscle fatigue, 
but in combination with other fatigue-induced changes or 
in an indirect manner (Westerblad 2016). It should also be 
highlighted that muscle fatigue is multi-factorial phenom-
enon. Skeletal muscle fatigue is generally accompanied by 
a marked slowing of relaxation (Allen et al. 2008).  H+ are 
proposed to directly or indirectly inhibit sarcoplasmic  Ca2+ 
release during skeletal muscle contraction (Laver et  al. 
2000, 2004). Carnosine has the potential to serve as a cyto-
plasmic regulator of  Ca2+ and  H+ coupling, since it binds to 
both ions (Baran 2000). As such, it could be hypothesised 
that increasing muscle carnosine content, via BA supple-
mentation, would have a more pronounced beneficial effect 
on HRT when the muscle is fatigued (Bergstrom and Hult-
man 1988).
The present study aimed to examine the effects of 28 
days of BA supplementation on intrinsic in-vivo isometric 
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knee extensor force production and muscle contractility in 
both fresh (rested conditions) and fatigued human skeletal 
muscle.
Methods
Ethical approval
All participants were fully informed of any risks and dis-
comforts associated with the study. Participants provided 
written informed consent and completed a health screen 
questionnaire prior to taking part in the study, which was 
first approved by the Nottingham Trent University Ethical 
Advisory Committee.
Participants
Twenty-four male participants were allocated to the two 
supplement groups [placebo (PLA) or BA] on the basis of 
maximal voluntary isometric force (MVIF) values recorded 
during familiarisation. One participant withdrew from the 
study (PLA group; n = 11) with no reason provided, and 
consequently, 23 participants completed all aspects of 
the study (PLA; age, 22 ± 1 years, height, 1.83 ± 0.06  m, 
body mass, 81.4 ± 14.2  kg, MVIF, 600 ± 149  N; and 
BA; age, 22 ± 2 years, height, 1.80 ± 0.05  m, body mass, 
76.0 ± 7.3  kg, MVIF, 565 ± 86 N). Participants had not 
ingested any nutritional supplements, had no injuries of the 
lower limb, and were not involved in any systematic physi-
cal training in the 6 months prior to the study. Participants 
were requested to maintain similar levels of physical activ-
ity and dietary intake, which was verbally confirmed at the 
start of each session. None of the participants were vegetar-
ian or vegan, and therefore, they would likely have encoun-
tered small amounts of BA in their diet.
Study design
This was a double-blind, placebo-controlled study with 
all raw data analyses, exclusions, and statistical analyses 
undertaken blind to the supplement group. Participants 
undertook three experimental sessions; a familiarisation 
session, which preceded a baseline session by ~7 days, 
and a follow-up session after 28 days of supplementation. 
Participants were instructed to abstain from alcohol and 
strenuous/unaccustomed exercise for 36 h before measure-
ment sessions, with caffeine prohibited on the day of test-
ing. Compliance with these requests was confirmed ver-
bally with participants before commencing each session. 
Measurement sessions recorded force and surface electro-
myography (EMG) during a series of voluntary and invol-
untary (electrically evoked) isometric contractions of the 
knee extensors of the dominant leg. All participants were 
first familiarised with the protocol measures, both baseline, 
and follow-up sessions involved an identical protocol per-
formed according to a strict schedule.
Supplementation
Participants were provided with 6.4 g day−1 of either BA 
(sustained-release CarnoSyn™; NAI, Inc. San Marcos, 
USA) or a matched PLA (maltodextrin; NAI, Inc. San 
Marcos, USA) for 28 days (2 × 800 mg tablets, ingested 4 
times per day). Based on similar BA supplementation pro-
tocols muscle carnosine content was expected to increase 
to ~ 38 mmol·kg−1 dry muscle (based upon a 65% increase 
from a baseline concentration of 23  mmol·kg−1 dry mus-
cle) or 65% above the typical carnosine content of indi-
vidual eating a mixed diet (Harris et  al. 2006; Sale et  al. 
2013). The sustained-release formulation used in this study 
has been shown to reduce or remove the paraesthesia often 
experienced by participants following doses of free BA 
powder (Decombaz et  al. 2012). Supplement compliance 
was verified with participant logs. Compliance was simi-
lar in both groups and was reported as 91 ± 6% (BA) and 
92 ± 9% (PLA; independent sample t test, P = 0.68); no 
feelings of paraesthesia were reported. Supplements were 
provided in identical white tubs by an individual blind to 
the supplement groups. BA tablets were tested by the man-
ufacturer before release for the study and conformed to the 
label claim for BA content. To ensure no contamination 
with steroids or stimulants according to the International 
Organization for Standardization (IOS) 17,025 accredited 
tests, the BA and PLA supplements were independently 
tested by HFL Sports Science.
Experimental setup
The experimental setup for the determination of isomet-
ric knee extension force, EMG, and electrical stimulation 
in our laboratory has been described in detail previously 
(Hannah et al. 2015).
Isometric knee extension force
The participant was strapped into a custom-built dynamom-
eter with knee and hip joint angles of ~95 and 100° (180° 
= full extension), and with an ankle cuff attached ~2  cm 
proximal to the medial malleolus secured around the par-
ticipant’s dominant leg, and which was in series with a 
linear strain gauge (Model 615; Tedea-Huntleigh, Her-
zliya, Israel). The chair position, strain gauge position, and 
strapping setup were recorded during the familiarisation 
session and replicated identically during subsequent test-
ing sessions. Force signals were amplified (×1,000) in the 
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frequency range of 0–500  Hz, sampled at 2000  Hz using 
an external A/D converter (Model 1401; CED, Cambridge, 
UK), interfaced with a personal computer (PC) using the 
Spike 2 software (CED). Force data were low-pass filtered 
in both directions at 450 Hz using a fourth-order zero-lag 
Butterworth filter before analysis. Baseline resting force 
was subtracted from all force recordings to correct for the 
effects of gravity.
Electromyography
EMG signals were recorded from the superficial quadri-
ceps: m. rectus femoris (RF), m. vastus medialis (VM), and 
m. vastus lateralis (VL). EMG signals were pre-amplified 
by active EMG leads (input impedance: 100 MΩ; com-
mon mode rejection ratio: >100 dB; base gain: 500; first 
order high-pass filter set to 10  Hz; Noraxon, Scottsdale, 
AR) connected in series to a custom-built junction box and 
subsequently to the same analogue–digital converter and 
PC software that enabled synchronisation with the force 
data. The signals were sampled at 2000  Hz. EMG data 
were band-pass filtered in both directions between 20 and 
450  Hz using a fourth-order zero-lag Butterworth filter 
before analysis.
Electrical stimulation
Knee extensor contractile properties were assessed using 
a constant current variable voltage stimulator (DS7AH; 
Digitimer, Welwyn Garden City, UK). Square-wave pulses 
(0.2  ms duration) were delivered via: (1) supramaximal 
femoral nerve stimulation to evoke maximal resting twitch, 
potentiated twitch, and octet contractions; and (2) percu-
taneous submaximal muscle stimulation to evoke contrac-
tions at a range of frequencies (1 to 100 Hz) to assess the 
force–frequency relationship. A cathode stimulation probe 
(1  cm diameter; Electro-Medical Supplies, Wantage, UK) 
and an anode (7 × 10  cm carbon rubber electrode; Elec-
tro- Medical Supplies) were used to elicit femoral nerve 
stimulation. Two carbon rubber electrodes (14 × 10  cm; 
Electro-Medical Supplies) were used to elicit percutaneous 
stimulation.
Protocol and measurements
Identification of force and EMG onset for all evoked and 
voluntary contractions was conducted manually using 
visual identification (Hannah et  al. 2012, 2015), which is 
considered more valid than the use of automated identifi-
cation methods (Tillin et al. 2013). Voluntary and evoked 
contractions were elicited in accordance with a previously 
published method (Hannah et  al. 2012, 2015; Tillin et  al. 
2013) and are described below in brief.
Resting twitches
A single electrical impulse was delivered with stepwise 
increments in the current to evoke a twitch response, until 
a plateau in the amplitude of twitch force and compound 
muscle action potentials (M-waves) was reached. To ensure 
supramaximal stimulation, stimulus intensity was increased 
by 25% above the value required to evoke a plateau. Three 
discrete supramaximal stimuli were then evoked to elicit 
maximal twitch responses and M-waves. Electromechanical 
delay (EMD) was defined as the time difference between 
M-wave onset (1st electrode site to be activated) and force 
onset. Twitch force at 25 and 50 ms from force onset, was 
measured as markers of the explosive force production, 
peak force, time-to-peak tension (TPT), and half-relaxation 
time (HRT) were also reported. All measurements were 
averaged across the three maximal twitch contractions. 
The M-wave response for the three quadriceps electrodes 
was measured for M-wave area, from EMG onset to the 
point where the signal returned to baseline, and averaged 
across the three sites. The mean M-wave area of the three 
supramaximal stimuli was defined as the maximal M-wave 
area (Mmax) and was used for normalisation of voluntary 
quadriceps EMG.
Maximum voluntary contractions and potentiated twitches
Participants were instructed to produce four maximal vol-
untary isometric contractions (MVIC), “as hard as possi-
ble” for 3–4 s. Strong verbal encouragement reiterating the 
instructions was provided during and after each contraction, 
together with visual onscreen feedback. Following each 
MVIC, supramaximal stimulation of the femoral nerve at 
the same configuration and stimulus intensity as the resting 
twitches was elicited to evoke maximal potentiated twitch. 
MVIF was defined as the greatest instantaneous force dur-
ing either the knee extensor MVICs or explosive voluntary 
contractions (see below). The root mean square (RMS) of 
the EMG signal for each muscle (RF, VM, and VL) was 
calculated over a 500 ms epoch surrounding MVIF (250 ms 
either side) and normalized to the corresponding Mmax. All 
sites were then averaged to calculate a mean quadriceps 
value. EMD, force at 25 and 50 ms from onset, peak twitch 
force, TPT, and HRT were averaged across the four maxi-
mal potentiated twitch contractions.
Explosive voluntary contractions
Participants completed isometric explosive voluntary con-
tractions, starting each contraction completely relaxed, 
contracting their knee “as fast and hard as possible” for 
~1  s, with an emphasis on “fast”. The three contractions 
with the greatest maximum rate of force development, 
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achieving the following criteria, were used for analysis: 
(1) no prior countermovement or pretension, and (2) peak 
force >80% MVIF. Explosive force was measured at 25 ms 
intervals up to 150 ms after force onset. The RMS of the 
EMG signal from each muscle was measured over three 
consecutive 50  ms time periods from EMG onset of the 
first agonist muscle to be activated (i.e., 0–50, 50–100, and 
100–150 ms). Thereafter, RMS at each EMG site was nor-
malized to Mmax and averaged to provide a mean quadri-
ceps value. All measurements were averaged across the 
three selected contractions.
Force–EMG relationship (via voluntary incremental knee 
extension contractions)
Submaximal knee extensor contractions were completed 
at 15% increments of MVIF, in ascending order, separated 
by ≥20 s. Force target levels were displayed on screen by 
horizontal cursors, with participants instructed to reach the 
target as quickly as possible, and then maintain this target 
force level as accurately as possible for ~3 s. During each 
contraction intensity, the RMS of the EMG and average 
force over a stable  500  ms part of the force trace (mini-
mal standard deviation of the force trace for that contrac-
tion). The EMG RMS values were normalized to Mmax and 
plotted against the respective force values. Linear regres-
sion was used to evaluate the slope and intercept of the 
force–EMG relationship incorporating all data between 15 
and 90% MVIF.
Octet contractions
Octet contractions (8 impulses at 300 Hz) were evoked via 
supramaximal stimulation of the femoral nerve. In sum-
mary, three discrete pulses (≥15  s apart) were delivered 
with a supramaximal current (+25%) to evoke maximal 
octet contractions. The octet force response was measured 
at 25 and 50 ms from force onset, as well as at the peak. 
All measurements were averaged across the three analysed 
contractions.
Force–frequency relationship
Tetanic contractions were elicited via submaximal percu-
taneous electrical stimulation of the quadricep to exam-
ine the force–frequency relationship (Lamont and Miller 
1992). 100 Hz contractions were evoked at increasing cur-
rent intensities, ≥30 s apart, to determine the current that 
elicited 50% of MVIF. This current was then used for the 
following force–frequency measurements. The final cali-
bration contraction at 100  Hz and the subsequent meas-
ured contractions were separated by ≥60 s. The force–fre-
quency relationship contractions consisted of two twitch 
contractions (1 Hz), followed by single contractions of 1 s 
duration at each of nine different frequencies (5, 10, 15, 20, 
30, 40, 50, 80, and 100 Hz) performed in ascending order 
with ≥30 s between contractions. Peak force was defined as 
the greatest instantaneous force. Thereafter, the force val-
ues at each stimulation frequency were normalized to the 
force obtained at 100 Hz. The force–frequency relationship 
was fitted with a Hill curve and evaluated for frequency 
at 50% of the maximum force response (Dutka and Lamb 
2004).
Sustained isometric knee extensor hold
To induce  H+ accumulation within the quadricep muscles, 
participants were instructed to perform a voluntary isomet-
ric contraction at 45% of MVIF for “as long as possible”. 
The start of the sustained fatigue hold was defined as the 
time when force was greater than 40% of MVIF, and ter-
minated when force fell below 5% of the target force for 
more than 3  s, despite strong encouragement. Strong ver-
bal encouragement was provided alongside visual feedback 
displayed onscreen. The time between start and end of 
the sustained fatigue was defined as the time-to-task fail-
ure (TTF), with average force recorded across this time. 
Impulse (kN.s) was calculated as the product of the aver-
age force and TTF. It has been estimated that TTF would 
be ~78 s for a contraction held at 45% of MVIC force (Ahl-
borg et al. 1972). Immediately upon completion of the sus-
tained fatigue hold, participants repeated all voluntary and 
evoked contractions.
Blood samples
Fingertip capillary blood samples were taken at rest, imme-
diately prior to and 5 min following the sustained fatigue 
hold. Fingertip capillary blood lactate measured 5  min 
post-exercise provides an estimate of lower limb blood lac-
tate contractions (Comeau et al. 2011). Sampling involved 
the collection of 80 µL of whole blood into a heparin-
coated clinitube; all samples were analysed immediately 
post-sampling (Radiometer Ltd, UK).
Statistical analysis
Based on an a priori power calculation, a minimum of 
22 participants were required to achieve 92% power at 
P < 0.05. Calculations were based on the previous findings 
(Hobson et al. 2012), with 24 participants being recruited 
to allow for dropouts. Statistical analyses were completed 
using SPSS version 22 (SPSS Inc., Chicago, IL, USA), 
with statistical significance accepted at P ≤ 0.05. Data are 
presented as means ± 1 standard deviation (SD). Depend-
ent variables (MVIF, EMD, HRT, TPT, slope, and intercept 
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of force–EMG relationship, frequency at 50% of force 
response for the force–frequency relationship) were evalu-
ated using a two-way mixed-model (group × session) analy-
sis of variance (ANOVA). Dependent variables measured 
over several time points (force and EMG during explosive 
voluntary contractions, evoked twitch, and octet force) 
were analysed using a three-way mixed-model (group × ses-
sion × time) ANOVA. All variables were assessed during 
both fresh and fatigued conditions. The sustained fatigue 
time-to-task failure (TTF) and impulse were analysed using 
a two-way mixed-model ANOVA.
The impact of the fatigue hold contraction on depend-
ant variables (MVIF, EMD, HRT, TPT, slope, and inter-
cept of force–EMG relationship, frequency at 50% of force 
response for the force–frequency relationship) was analysed 
using a three-way mixed-model (fatigue × group × session) 
ANOVA. Percentage change between fresh and fatigued 
values for the dependent variables measured over sev-
eral time points (force and EMG during explosive volun-
tary contractions, evoked twitch, and octet force) were 
analysed using a three-way mixed-model (percentage 
change × group × session) ANOVA. A Greenhouse–Geis-
ser correction was applied when the ANOVA assumption 
of sphericity was violated. Effect size for multiple com-
parisons was calculated using partial (휂2
p
) and generalised 
(휂2
g
) eta squared (Lakens 2013). Providing two effect sizes 
is suggested to yield a greater understanding of a specific 
effect (Preacher and Kelly 2011). Post hoc comparisons 
to explain any significant interactions are reported with 
Cohen’s d effect size. An effect size of 0.2–0.5 was defined 
as small, 0.5–0.8 as medium, and ≥0.8 as large (Schüne-
mann et al. 2008). Intra-individual variability was assessed 
using the mean intra-individual coefficient of variation 
(CV) across the two measurement sessions for the PLA 
group [(SD/mean) × 100], the current research CVs are in 
line with those reported previously using the same equip-
ment (Hannah et al. 2015).
Results
Electrically evoked contractile properties
Resting twitches
Supplementation did not significantly influence twitch 
force, EMD, or TPT (Table 1). There was, however, a sig-
nificant group × session interaction for HRT in both fresh 
(P = 0.04, n2
p
 = 0.2, n2
g
 <0.001) and fatigued (P = 0.03, 휂2
p
 = 
0.2, 휂2
g
 = 0.1; Figs. 1, 2) muscle. Post hoc analysis showed 
that the percentage change in fresh muscle HRT was not 
significantly different between the BA (−2 ± 10 ms; −3 ± 
13%) and PLA group (+8 ± 16 ms; 8 ± 16%) with a large 
effect reported (P = 0.06; Cohen’s d = 0.9). In fatigued 
muscle, post hoc analysis showed that HRT percentage 
change was significantly different between the BA (−25 ± 
34 ms; −19 ± 26%) and PLA (8 ± 16 ms; 0 ± 15%) group 
with a large effect reported (P = 0.05, Cohen’s d = 0.9).
Table 1  Electrically femoral nerve evoked force responses, time-to-peak tension (TPT), and electromechanical delay (EMD) of β-alanine (BA) 
and placebo (PLA) groups pre- and post-supplementation, in fresh and fatigued muscle. Data are means ± 1SD
Pre-supplementation Post-supplementation
Force (N) EMD (ms) TPT (ms) Force (N) EMD (ms) TPT (ms)
25 50 Peak 25 50 Peak
Resting twitch
 Fresh BA 23 ± 5 73 ± 14 88 ± 17 10 ± 1 79 ± 11 24 ± 6 73 ± 17 90 ± 19 10 ± 1 81 ± 9
 Fresh PLA 28 ± 4 79 ± 19 99 ± 26 11 ± 1 82 ± 8 29 ± 5 82 ± 16 104 ± 24 10 ± 1 83 ± 9
 Fatigued BA 22 ± 7 61 ± 22 68 ± 25 11 ± 2 72 ± 16 26 ± 8 71 ± 22 79 ± 23 10 ± 1 74 ± 13
 Fatigued PLA 25 ± 6 58 ± 20 65 ± 24 11 ± 1 69 ± 8 24 ± 4 60 ± 15 67 ± 18 10 ± 2 71 ± 9
Potentiated twitch
 Fresh BA 55 ± 13 142 ± 24 159 ± 26 9 ± 1 79 ± 6 53 ± 8 136 ± 14 155 ± 9 9 ± 1 81 ± 6
 Fresh PLA 60 ± 16 138 ± 37 163 ± 43 9 ± 1 79 ± 9 59 ± 10 142 ± 34 167 ± 38 9 ± 1 82 ± 8
 Fatigued BA 37 ± 11 92 ± 27 101 ± 29 11 ± 1 74 ± 9 40 ± 9 101 ± 19 110 ± 18 10 ± 1 73 ± 10
 Fatigued PLA 42 ± 10 93 ± 25 105 ± 30 10 ± 1 74 ± 4 38 ± 9 93 ± 23 106 ± 28 10 ± 1 74 ± 8
Octet
 Fresh BA 52 ± 15 165 ± 42 223 ± 47 7 ± 2 117 ± 25 64 ± 18 196 ± 37 274 ± 53 7 ± 2 120 ± 24
 Fresh PLA 66 ± 17 190 ± 62 285 ± 94 6 ± 1 127 ± 19 64 ± 17 199 ± 60 296 ± 94 7 ± 2 137 ± 7
 Fatigued BA 62 ± 23 191 ± 49 221 ± 72 7 ± 2 100 ± 23 62 ± 17 182 ± 47 244 ± 68 7 ± 2 114 ± 25
 Fatigued PLA 69 ± 20 191 ± 49 273 ± 72 7 ± 1 123 ± 14 64 ± 16 198 ± 49 283 ± 79 7 ± 2 125 ± 15
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The percentage difference between fresh and fatigued 
resting twitch force remained similar between sessions for 
both supplementation groups. Resting twitch TPT declined 
following completion of the sustained fatigue hold 
(P = 0.001, 휂2
p
휂
2
p
 = 0.4, 휂2
g
 = 0.2), although EMD remained 
similar with no difference between sessions or groups 
(Table 1). Resting twitch HRT significantly increased fol-
lowing the completion of the sustained fatigue hold (P 
<0.001, n2
p
 = 0.7, n2
g
= 0.3; Fig. 1) with no group × fatigue 
or group × session × fatigue interactions.
Potentiated twitches
Supplementation did not significantly influence twitch 
force, EMD or TPT (Table 1). There was, however, a sig-
nificant group × session interaction for HRT in both fresh 
(P  =  0.03, n2
p
= 0.2, n2
g
 <0.001) and fatigued muscle 
(P = 0.03,휂2
p
= 0.2, 휂2
g
 < 0.001; Figs. 1, 2). Post hoc analy-
sis showed that the percentage change in fresh muscle HRT 
was not significantly different between the BA (0 ± 9 ms; 
+1 ± 15%) and PLA group (+7 ± 10 ms; +12±15%) with 
a medium effect reported (P = 0.10, Cohen’s d = 0.7). In 
fatigued muscle, post hoc analysis showed that the percent-
age change in fatigued muscle HRT was significantly dif-
ferent between the BA (−2.7 ± 16 ms; −2 ± 20%) and PLA 
group (12 ± 12 ms; 16 ± 17%) with a large effect reported 
(P = 0.03, Cohen’s d = 1.0).
The percentage difference between fresh and fatigued 
potentiated twitch force remained similar between ses-
sions for both supplementation groups, with only a sig-
nificant effect of time (P = 0.001, 휂2
p
 = 0.5, 휂2
g
 = 0.5). 
Potentiated twitch TPT declined following completion of 
the sustained fatigue hold (P < 0.001, 휂2
p
 = 0.5, 휂2
g
 = 0.5; 
Table 1). Potentiated EMD significantly prolonged follow-
ing the fatigue hold (P = 0.001, 휂2
p
 = 0.45, 휂2
g
 = 0.2) with 
no group × fatigue or group × session × fatigue interactions. 
Potentiated HRT significantly increased following the com-
pletion of the sustained fatigue hold (P < 0.001, 휂2
p
= 0.7, 
휂
2
g
 = 0.4; Fig.  1), with no group × fatigue or group × ses-
sion × fatigue interactions.
Octet contractions
In both fresh and fatigued muscle, supplementation did not 
significantly alter octet peak force, EMD or TPT (Table 1). 
There was, however, a significant group × session interac-
tion for octet HRT in both fresh (P = 0.05; n2
p
 = 0.2; 휂2
g
 = 
0.1) and fatigued (P = 0.01; n2
p
 = 0.3; 휂2
g
 = 0.2; Figs.  1, 
2) skeletal muscle. Post hoc analysis showed that the per-
centage change in fresh muscle was significantly differ-
ent between the BA (−26±30  ms; −20  ±  22%) and PLA 
(0 ± 32 ms; 1 ± 34%) group with a large effect reported 
Fig. 1  Electrically evoked 
half-relaxation time of 
β-alanine (BA) and placebo 
(PLA) groups pre- and post-
supplementation, in fresh and 
fatigued muscle during: resting 
twitch (a), potentiated twitch 
(b), and octets (c). Data are 
means ± 1SD. **P ≤ 0.01 and 
*P ≤ 0.05 for post hoc inde-
pendent t-test between BA and 
PLA groups
Fig. 2  Representative records of the force response during an elec-
trically evoked resting twitch contraction pre- and post-supplemen-
tation with β-alanine under fresh conditions. These records are aver-
aged records from three participants to provide an illustration of the 
decline in twitch half-relaxation time
 Eur J Appl Physiol
1 3
(P = 0.05, Cohen’s d = 0.8). In fatigued muscle, post hoc 
analysis showed that HRT percentage change was sig-
nificantly different between the BA (−11 ± 20 ms; −11 ± 
20%) and PLA (12 ± 19 ms; 7 ± 13%) groups with a large 
effect reported (P = 0.01, Cohen’s d = 1.2).
Octet force percentage change between fresh and 
fatigue was not significantly affected by supplementa-
tion. Octet TPT (P = 0.05, 휂2
p
 = 0.2, 휂2
g
 = 0.1; Table 1) and 
HRT (P = 0.008, 휂2
p
 = 0.3, 휂2
g
 = 0.2; Fig. 1), declined fol-
lowing completion of the sustained fatigue hold with no 
group × fatigue or group × session × fatigue interactions. 
Octet EMD was not significantly influenced following 
the fatigue hold, with no group × fatigue or group × ses-
sion × fatigue interactions (Table 1).
Force–frequency relationship
Supplementation did not significantly influence peak force 
at each frequency of stimulation, and the frequency at 50% 
of the force response (Table 2) in either fresh or fatigued 
muscle. Following the fatigue hold, peak force significantly 
declined (P = 0.001, 휂2
p
 = 0.8, 휂2
g
 = 0.2), although the fre-
quency at 50% of the force response remained unaffected.
Maximum and explosive voluntary force production
Supplementation had no effect on MVIF in fresh or fatigued 
muscle (Fig. 3a). Following the fatigue hold, MVIC signifi-
cantly declined (P < 0.001, 휂2
p
 = 0.9, 휂2
g
 = 0.2), with no dif-
ferences between session and groups (BA: 17–18%; PLA: 
21%; Fig. 3a). There was no effect of supplementation on 
force measures at 25  ms intervals during explosive vol-
untary contractions in fresh and fatigued states (Fig.  3a). 
Explosive force percentage change between fresh and 
fatigue of force remained unaffected by supplementation.
Neuromuscular activation
Agonist neuromuscular activation during maximal 
and explosive voluntary contractions
Agonist EMG normalized to Mmax during MVICs and 
explosive contraction remained uninfluenced by supple-
mentation in fresh and fatigued muscles (Fig. 3b).
Force–EMG relationship
The slope and y-intercept of the force–EMG relationship 
were unaffected by supplementation in both fresh and 
fatigued muscles (Fig. 4; Table 2). The percentage change 
in agonist EMG normalized to Mmax during MVICs and 
explosive contraction was not significantly altered between 
sessions. Ta
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Sustained isometric knee extensor hold
TTF was unaffected by BA (pre: 63.2 ± 13.0  s; post: 
63.4 ± 15.3 s) or PLA supplementation (pre: 77.3 ± 24.8 s; 
Post: 75.3 ± 18.9  s). Impulse was also not significantly 
influenced by BA (pre: 16.1 ± 3.5 kN  s−1; post 16.4 ± 4.6 
kN  s−1) or PLA supplementation (pre: 19.6 ± 4.4 kN  s−1; 
post 19.4 ± 3.2 kN  s−1). Blood lactate concentrations at 
rest and prior to the sustained fatigued hold were not sig-
nificantly different (Table 3). Blood lactate concentrations 
significantly increased 5  min following the sustained iso-
metric knee extensor hold compared to both rest and prior 
to values (P < 0.001, 휂2
p
 = 0.8, 휂2
g
 = 0.6), with no difference 
between sessions or group (Table 3).
Discussion
The key findings from the present study are: (a) no effects 
of BA supplementation on isometric force production 
capacity in either fresh or fatigued skeletal muscle, (b) the 
confirmation of our previous findings (Hannah et al. 2015) 
showing altered fresh muscle relaxation speed following 28 
days of BA supplementation, and (c) that the skeletal mus-
cle relaxation speed is also reduced by BA supplementation 
following muscle fatigue in the absence of any change to 
peak force production or contraction time compared to the 
PLA group. The current investigation examined the influ-
ence of BA supplementation on neuromuscular perfor-
mance measures, associated with  Ca2+ handling within the 
skeletal muscle, a proposed mechanism associated with the 
improvements in exercise performance (Dutka and Lamb 
2004; Everaert et  al. 2013; Guglielmi et  al. 2013; Sale 
et al. 2013) in fresh and fatigued muscle conditions. These 
data are the first to comprehensively examine the effect of 
BA supplementation on voluntary and electrically evoked 
contractile properties of in-vivo fatigued human skeletal 
muscle.
During both fresh and fatigued conditions, BA supple-
mentation has no effect on voluntary isometric force pro-
duction including maximal and explosive force variables. 
Voluntary force peak data are consistent with the lack of 
change in electrically evoked peak force responses noted 
during twitch and octet contractions under both fresh 
and fatigued conditions. There were similar neural drive 
responses during both MVICs and explosive contractions 
pre- and post-supplementation in fresh and fatigued mus-
cle. The current findings in fresh muscle are in-line with the 
previous findings (Hannah et al. 2015), it was proposed that 
if BA supplementation had influenced  Ca2+ related func-
tion, improved explosive voluntary force and/or alterations 
in the force–EMG relationship would have been evident.
Fig. 3  Explosive and maximal voluntary isometric force (MVIF) 
responses (a), and agonist EMG normalized to M-wave area  (Mmax) 
during explosive contractions (0–50, 50–100, and 100–150  ms 
from onset) and at MVIF (b) for the BA and PLA groups pre- and 
post-supplementation, in fresh and fatigued muscles. Data are 
means ± 1SD
Fig. 4  Force–EMG relationship measured during submaximal volun-
tary contractions (15–90% MVIF) for the BA and PLA groups pre- 
and post-supplementation, in fresh and fatigued muscles. Data are 
means ± 1SD
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In both fresh and fatigued in-vivo human skeletal mus-
cles, there was no leftward shift of the force–frequency 
curve, the associated measure of intracellular  Ca2+ levels 
(Batrukova and Rubstov 1997). Thus suggesting that eleva-
tion of carnosine concentrations did not significantly alter 
 Ca2+-related function. That said,  there may have been a 
decline in sarcoplasmic reticulum  Ca2+ release which was 
not documented in the force–frequency curve, due to an 
associated increase in  Ca2+ sensitivity of the myofibrils, 
resulting in the same skeletal muscle force. The current 
research in fresh muscle is in line with the previous in-vivo 
research (Hannah et al. 2015), where increased muscle car-
nosine concentration following a similar 28-day BA supple-
mentation protocol did not alter the force–frequency curve. 
One potential limitation of both studies is that neither 
measured intracellular carnosine concentrations directly. 
That said there are many studies displaying increased mus-
cle carnosine following BA supplementation, almost with-
out exception, on an individual-by-individual basis (Har-
ris et al. 2006; Hill et al. 2007). Thus, we are confident in 
assuming that a significant increase in muscle carnosine 
content would have occurred with the BA supplementation 
protocol implemented in the present study.
The lack of an effect of BA on TPT and force produc-
tion following increased carnosine concentrations is inter-
esting. Based on the previous in-vitro studies in chemi-
cally skinned muscle fibres from frogs (Lamont and Miller 
1992), mechanically skinned rat muscle fibres (Dutka and 
Lamb 2004) and type I and type II human skeletal mus-
cle fibres (Dutka et al. 2012), an alteration to submaximal 
action potential-mediated force responses via increased 
 Ca2+ sensitivity could have been expected. Furthermore, 
the current investigation reported no alteration to potenti-
ated twitch contractions. Given that the phosphorylation 
of the myosin head during these twitches is impacted by 
 Ca2+ sensitivity, any impact of increased carnosine con-
centrations would have been displayed as a resultant effect 
on these measures. In-vitro data following BA supplemen-
tation in mice reported increased carnosine (+156%) and 
anserine content (+46%) in the extensor digitorum lon-
gus muscle and a marked leftward shift of the force–fre-
quency relationship (Everaert et al. 2013). These alterations 
to skinned muscle fibre  Ca2+ handling when exposed to 
increased carnosine concentrations are interesting, although 
both the previous (Hannah et al. 2015) and current in-vivo 
studies suggest that these responses might not be signifi-
cant enough to be evident during whole muscle contraction. 
It might be that the differences between these in-vitro data 
(where carnosine can be indirectly elevated to a consistent 
level) and the data from the current study reflect differ-
ences in the magnitude of intramuscular carnosine eleva-
tion, which we, unfortunately, cannot confirm in the cur-
rent study. It is also important to note that in-vitro research 
is conducted outside the normal intracellular environment, 
and importantly, a number of protocols include the use of 
free magnesium, an inhibitor of skeletal muscle ryanodine 
receptors (Laver et al. 2004). Furthermore, during in-vitro 
studies solutions are added to control pH levels allowing 
examination of the direct effect of carnosine, although this 
is important, these investigations have yet to examine the 
influence of carnosine concentration and varying pH levels. 
The current body of in-vivo research is completely separate 
from the in-vitro data, which might make it unrealistic to 
expect similar findings between research designs.
Increasing muscle carnosine concentrations with 28 
days of BA supplementation resulted in a shorter HRT 
(relative to equivalent PLA times) in fresh and fatigued 
skeletal muscle during both resting and potentiated twitch 
contractions. These are in contrast with HRT in fresh and 
fatigued resting and potentiated twitch contractions follow-
ing PLA supplementation. The altered muscle HRT values 
in the current investigation are in-line with those previously 
reported following the same BA supplementation protocol 
(7–12%; Hannah et al. 2015). Muscle relaxation speed has 
been associated with both  Ca2+ removal from the myo-
plasm  (Ca2+ component) and  Ca2+ dissociation from tro-
ponin followed by cross-bridge detachment (cross-bridge 
component) (Westerblad et  al. 1997). Research conducted 
by Westerblad and Allen (1993),  in fatigued mouse mus-
cle fibres, suggested that the slowing of muscle relaxation, 
apparent under fatigued conditions, was a reflection of 
slowed cross-bridge kinetics, rather than a reduction in the 
rate of  Ca2+ decline at the end of the stimulation train. Yet, 
when these data were repeated in Xenopus muscle fibres, 
the slowing of muscle relaxation was associated with a 
combination of altered cross-bridge kinetics and impaired 
Table 3  Blood lactate concentrations (mmol·l− 1) for the BA and PLA groups pre- and post-supplementation, at rest, prior to, and 5 min follow-
ing the completion of the sustained fatigue hold (+5 min)
Significant differences between concentrations are denoted by * (rest and +5 min) and X (prior to and +5 min). Data are means ± 1SD
Pre-supplementation Post-supplementation
Rest (mmol·l− 1) Prior to (mmol·l− 1) +5 min (mmol·l− 1) Rest (mmol·l− 1) Prior to (mmol·l− 1) +5 min (mmol·l− 1)
BA 1.0 ± 0.3 1.1 ± 0.2 3.8 ± 1.1* X 1.2 ± 0.3 1.3 ± 0.4 3.7 ± 1.3* X
PLA 1.0 ± 0.3 1.1 ± 0.4 3.8 ± 1.3* X 1.3 ± 0.3 1.2 ± 0.2 4.2 ± 1.0* X
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 Ca2+ handling, rather than just slowed cross-bridge kinet-
ics alone. As such, the decline in skeletal muscle HRT fol-
lowing 28 days of BA supplementation shown in the cur-
rent investigation may be associated with alterations to 
skeletal muscle cross-bridge kinetics. Alternatively, the 
decrease in HRT may be associated with the  Ca2+ com-
ponent of skeletal muscle relaxation speed, given that it 
has been proposed that  Ca2+ re-uptake by the sarcoplas-
mic reticulum  Ca2+-ATPase (SERCA) is the rate-limiting 
step in muscle relaxation (Gillis 1985; Dux 1993). The 
transfer of  Ca2+ into the SR lumen by the SERCA pump 
is accompanied by a counter-transport of  H+ out into the 
cytosol (Tran et al. 2009), by acting on  Ca2+-handling pro-
teins directly or via other molecules,  Ca2+ signalling can be 
inhibited or excited (Swietach et al. 2013). The presence of 
carnosine has already been shown to improve isolated rat 
heart muscle contraction and increases free intracellular 
 Ca2+ concentrations (Zaloga et  al. 1996). At a pH of 6.0, 
where a complete decline in  Ca2+ release pump activity 
was evident, the presence of carnosine maintained ~30% 
of pump activity at the same pH. Although speculative, 
these data suggest that increasing carnosine concentrations 
might alter  Ca2+-channel activity by interacting with the 
 Ca2+-channel itself (Batrukova and Rubstov 1997), possi-
bly via the existence of saturable binding site(s) for carno-
sine on the  Ca2+-channel. These data are, however, limited 
by a number of methodological factors, including but not 
limited to, the lack of a  Ca2+ buffer, the overloading of the 
sarcoplasmic reticulum with  Ca2+ concentrations approxi-
mately ten times greater than normal, and the addition of 
un-physiological magnesium concentrations. As such, care 
needs to be taken over the interpretation of these find-
ings. Alternatively, the decrease in HRT may be mediated 
through improved pH control in the microenvironment of 
the  Ca2+ release pump where rapid ATP hydrolysis will 
result in increased release of protons. There could also be 
an indirect mechanism to explain the beneficial effects dis-
played within the current investigation in regards to mus-
cle relaxation. Given the number of other proteins that bind 
to  Ca2+-channels (Berchtold et  al. 2000), carnosine may 
alter the protein interactions with the  Ca2+-channels and/
or bind with the proteins themselves; both of these mecha-
nisms could influence the activity of the  Ca2+-channel via 
increased carnosine concentrations.
Although the mechanism for reducing skeletal muscle 
relaxation time following BA supplementation remains 
unclear, such an outcome might be beneficial to exercise 
performance, especially during short, repeated muscle con-
tractions where muscle relaxation comprises an important 
proportion of total energy consumption (Bergstrom and 
Hultman 1988). During concentric contractions, improve-
ment of muscle recovery time has been shown to be criti-
cal to the amount of post-shortening force decrease (Edman 
1975). Reducing relaxation rates may improve muscle 
power output and exercise performance. These findings 
are particularly important for activities where fast, repeti-
tive contractions, and relaxations occur with no period of 
rest. Future research is essential to confirm an effect of 
BA supplementation and/or muscle carnosine accumula-
tion on SERCA activity and to better understand how these 
isolated muscle effects might relate to repetitive sport-
ing movements and overall performance. It would be of 
benefit to repeat these data in elite athletes where small 
changes to HRT might be advantageous. Equally we might 
speculate that benefits may occur in clinical populations 
such as Brody disease (where SERCA1 activity is signifi-
cantly reduced; Guglielmi et  al. 2013) or Duchenne Mus-
cular Dystrophy (where an excess of cytosol  Ca2+occurs; 
Ohlendieck 2000).
Within the current investigation, isometric knee exten-
sor fatigue hold times were not significantly influenced by 
BA or PLA supplementation, in direct contrast to our previ-
ous findings that showed a 13.2% (9.7 ± 9.4 s) increase in 
45% hold times following BA supplementation (Sale et al. 
2012). The reason for a lack of a significant effect in the 
current study is unclear, given that isometric knee exten-
sor hold times reported by both investigations were similar 
and aligned to times predicted by the Rohmert equation at 
a 45% MVIC (78 s; Ahlborg et al. 1972). At 45% MVIC, 
blood flow is occluded and thus the active muscle fibres are 
largely dependent upon anaerobic energy provision (Ahl-
borg et  al. 1972). Blood lactate sampled from the finger 
5 min post-exercise is indicative of the lower extremity lac-
tate release (Comeau et al. 2011), with groups in the cur-
rent study displaying similar levels of lactate accumulation 
in the lower limb. To greater understand the relationship 
between skeletal muscle HRT, increased carnosine concen-
trations and muscle fatigue, further investigations imple-
menting a dynamic fatiguing protocol are required, since 
contractile slowing (i.e., prolonged half-relaxation time) 
would affect shortening velocity and power output (Jones 
et al. 2006).
Conclusion
The current investigation showed that 28 days of BA sup-
plementation enhanced muscle relaxation time in both 
fresh and fatigued skeletal muscle. Whilst this finding is 
of interest, it remains unclear as to whether it would be 
sufficient to result in improved exercise performance, par-
ticularly in the absence of any changes to the force–fre-
quency relationship, peak force production, or contraction 
time. The mechanism for the ergogenic effect on muscle 
relaxation following increased carnosine content remains 
unclear. It could however, be proposed that  Ca2+ re-uptake 
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via direct or indirect mechanisms associated with SERCA 
pump activity is involved, as this is the rate-limiting step of 
muscle relaxation.
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